Meta-Analysis And Meta-Regression Of The Prevalence Of Diabetic Peripheral Neuropathy Among Patients With Type 2 Diabetes Mellitus

Authors

  • Lidiane Ribeiro de Souza Universidade do Extremo Sul Catarinense (UNESC)
  • Debora Debiasi Universidade do Extremo Sul Catarinense (UNESC)
  • Luciane Bisognin Ceretta Universidade do Extremo Sul Catarinense (UNESC)
  • Priscyla Waleska Simões Universidade do Extremo Sul Catarinense (UNESC) http://orcid.org/0000-0003-1782-0542
  • Lisiane Tuon Universidade do Extremo Sul Catarinense (UNESC)

DOI:

https://doi.org/10.3823/1936

Keywords:

Type 2 Diabetes Mellitus. Diabetic Peripheral Neuropathy. Prevalence. Systematic review. Meta-analysis. Evidence-Based Healthcare.

Abstract

The aim of the present study was to investigate the prevalence of diabetic peripheral neuropathy (DPN) among patients with type 2 diabetes mellitus (DM) using a systematic review and meta-analysis. An electronic search was conducted in the PubMed, Embase, Cochrane and other databases. This search employed articles published from July 1983 to December 2014. Only cross-sectional studies conducted with individuals aged 18 to 75 years old that investigated the prevalence of DPN among type 2 DM were included. Meta-regression and sensitivity analyses were performed to investigate the sources of heterogeneity. Publication bias was assessed via funnel plots and the Begg test. The meta-analysis was performed using the R 3.1.1 software. The study selection process resulted in the inclusion of 27 articles in the meta-analysis. In total, the occurrence of DPN was investigated in 16.337 individuals with type 2 DM. The global prevalence of DPN among patients with type 2 DM was 35.78% (95% CI: 27.86-44.55%). The sensitivity analysis by continent where the studies were performed showed that the prevalence of DPN was higher in Europe (48.14%; 95% CI: 33.31-63.30%). A meta-regression analysis did not 44.91%). the any cofactors as a cause of the heterogeneity. Our data suggest that the prevalence of DPN among individuals with type 2 DM is high. Due to the impact of the complications of DPN on the quality of life of the affected patients and the cost of care for these complications, this condition should be considered a significant public health problem.

References

FID. Federação Internacional de Diabetes: IDF.org; 2015. 6ª. Available from: http://www.idf.org/.

Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J diabetes investig. 2014;5(6):714-21.

Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies a statement by the American Diabetes Association. Diabetes care. 2005;28(4):956-62.

Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes care. 2003;26(5):1553-79.

Sandireddy R, Yerra VG, Areti A, Komirishetty P, Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int j endocrinol. 2014;2014:10.

Katsuda Y, Sasase T, Tadaki H, Mera Y, Motohashi Y, Kemmochi Y, et al. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. Exp anim. 2015;64(2):161-9.

Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF, et al. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol metab syndr. 2014;6(1):139.

Wu J, Zhang X, Zhang B. Efficacy and safety of puerarin injection in treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. J tradit chin med. 2014;34(4):401-10.

Asad A, Hameed MA, Khan UA, Ahmed N, Butt MU. Reliability of the neurological scores for assessment of sensorimotor neuropathy in type 2 diabetics. J pak med assoc. 2010;60(3):166-70.

Caiafa JS, Castro AA, Fidelis C, Santos VP, Silva ES, Sitrângulo CJJ. Atenção integral ao portador de pé diabético. J vasc bras. 2011;10:1-32.

Dros J, Wewerinke A, Bindels PJ, Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann fam med. 2009;7(6):555-8.

Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin neurol neurosurg. 2006;108(5):477-81.

Mythili A, Kumar KD, Subrahmanyam KAV, Venkateswarlu K, Butchi RG. A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. Int j diabetes dev ctries. 2010;30(1):43-8.

Deeks J, Bossuyt P, Gatsonis C. Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0. 0 - The Cochrane Collaboration. Cochrane database syst rev. 2009.

Egger M, Smith GD, Altman D. Systematic reviews in health care: meta-analysis in context: John Wiley & Sons; 2008.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.

Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol methods. 2006;11(2):193-206.

Stanley TD, Doucouliagos H. Meta-regression approximations to reduce publication selection bias. Res synth methods. 2014;5(1):60-78.

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101.

Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J clin epidemiol. 2001;54(10):1046-55.

Langan D, Higgins JP, Gregory W, Sutton AJ. Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J clin epidemiol. 2012;65(5):511-9.

Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.

Whiting PF, Sterne JA, Westwood ME, Bachmann LM, Harbord R, Egger M, et al. Graphical presentation of diagnostic information. BMC med res methodol. 2008;8:20.

Abougalambou SS, Abougalambou AS. Explorative study on diabetes neuropathy among type II diabetic patients in Universiti Sains Malaysia Hospital. Diabetes metab syndr. 2012;6(3):167-72.

Acker K, Bouhassira D, Bacquer D, Weiss S, Matthys K, Raemen H, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes metab. 2009;35(3):206-13.

Al-Maskari F, El-Sadig M. Prevalence of risk factors for diabetic foot complications. BMC fam pract. 2007;8:59.

Bagavathiappan S, Philip J, Jayakumar T, Raj B, Rao PN, Varalakshmi M, et al. Correlation between plantar foot temperature and diabetic neuropathy: a case study by using an infrared thermal imaging technique. J diabetes sci technol. 2010;4(6):1386-92.

Bin-Lu, Hu J, Wen J, Zhang Z, Zhou L, Li Y, et al. Determination of Peripheral Neuropathy Prevalence and Associated Factors in Chinese Subjects with Diabetes and Pre-Diabetes – ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SHDREAMS). Plos one. 2013;8(4):e61053.

Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes care. 2011;34(10):2244-9.

Codogno JS, Fernandes RA, Sarti FM, Freitas Junior IF, Monteiro HL. The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study. BMC public health. 2011;11:275.

Delcourt C, Cathelineau BV, Kervroedan FV, Papoz L. Clinical correlates of advanced retinopathy in type II diabetic patients: implications for screening. The CODIAB-INSERM-Zeneca Pharma Study Group. J clin epidemiol. 1996;49(6):679-85.

Hamdan AL, Jabbour J, Barazi R, Korban Z, Azar ST. Prevalence of laryngopharyngeal reflux disease in patients with diabetes mellitus. J voice. 2013;27(4):495-9.

Hanley AJ, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, et al. Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors. Diabetes care. 2005;28(8):2054-7.

Jang EH, Park YM, Hur J, Kim MK, Ko SH, Baek KH, et al. Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with type 2 diabetes. Diabet med. 2013;30(6):694-701.

Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, et al. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta neurol scand. 2006;114(6):384-91.

Jarmuzewska EA, Mangoni AA. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes. J intern med. 2005;258(1):38-44.

Jianbo L, Yuche C, Ming S, Jingrong T, Qing D, Yu Z, et al. Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes res clin pract. 2011;93(1):38-42.

Kamenov ZA, Parapunova RA, Georgieva RT. Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus. Gend med. 2010;7(6):600-15.

Kastenbauer T, Irsigler P, Sauseng S, Grimm A, Prager R. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects. J diabetes complications. 2003;18(1):27-31.

Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch iran med. 2013;16(1):17-9.

Liang H, Murase Y, Katuta Y, Asano A, Kobayashi J, Mabuchi H. Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes. Clin endocrinol. 2005;63(3):317-22.

Liu F, Bao Y, Hu R, Zhang X, Li H, Zhu D, et al. Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China. Diabetes metab res rev. 2010;26(6):481-9.

Paisey RB, Arredondo G, Villalobos A, Lozano O, Guevara L, Kelly S. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects II. Diabetes care. 1984;7(5):428-33.

Pop-Busui R, Lu J, Lopes N, Jones TL, Investigators BD. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J peripher nerv syst. 2009;14(1):1-13.

Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet med. 2008;25(4):407-12.

Shaw JE, Hodge AM, Courten M, Dowse GK, Gareeboo H, Tuomilehto J, et al. Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes res clin pract. 1998;42(2):131-9.

Sloten TTV, Savelberg HH, Peeters IGD, Meijer K, Henry RM, Stehouwer CD, et al. Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations. Diabetes res clin pract. 2011;91(1):32-9.

Tahrani AA, Ali A, Raymond NT, Begum S, Dubb S, Mughal S, et al. Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am j pespir crit care med. 2012;186(5):434-41.

Voulgari C, Psallas M, Kokkinos A, Argiana V, Katsilambros N, Tentolouris N. The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes. J diabet complications. 2011;25(3):159-67.

Wang W, Balamurugan A, Biddle J, Rollins KM. Diabetic neuropathy status and the concerns in underserved rural communities: challenges and opportunities for diabetes educators. Diabetes educ. 2011;37(4):536-48.

Palma FH, Antigual DU, Martinez SF, Monrroy MA, Gajardo RE. Static balance in patients presenting diabetes mellitus type 2 with and without diabetic polyneuropathy. Arq bras endocrinol metabol. 2013;57(9):722-6.

Abrao L, Chagas JK, Schmid H. Periodontal disease and risk for neuropathic foot ulceration in type 2 diabetes. Diabetes res clin pract. 2010;90(1):34-9.

Jurado J, Ybarra J, Romeo JH, Pou JM. Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study. Eur j clin invest. 2009;39(3):183-9.

Mahroos FA, Roomi KA. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann saudi med. 2007;27(1):25-31.

Vaz MM, Costa GC, Reis JG, Junior WM, Paula FJA, Abreu DC. Postural control and functional strength in patients with type 2 diabetes mellitus with and without peripheral neuropathy. Arch phys med rehabil. 2013;94(12):2465-70.

Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes res clin pract. 2002;57(1):45-51.

Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle nerve. 1998;21(1):72-80.

Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MH, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol metab syndr. 2012;4(1):21.

Cardoso CR, Salles GF. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients. J diabetes complications. 2008;22(3):164-70.

Kasim K, Amar M, Sadek AAE. Peripheral neuropathy in type-II diabetic patients attending diabetic clinics in Al-Azhar University Hospitals, Egypt. Int j diabetes mellitus. 2010.

Morkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: a study of type 2 diabetic outpatients in Bangladesh. Int j diabetes dev ctries. 2010;30(1):11.

Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian j med sci. 2010;64(2):51-7.

Hussain G, Rizvi SA, Singhal S, Zubair M, Ahmad J. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy. Diabetes metab syndr. 2014;8(1):48-52.

Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ. Foot complications in Type 2 diabetes: an Australian population-based study. Diabet med. 2003;20(2):105-13.

Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ. Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes care. 2005;28(8):1869-75.

Gadia MT, Natori N, Ramos LB, Ayyar DR, Skyler JS, Sosenko JM. Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes care. 1987;10(5):613-6.

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes care. 2010;33(10):2285-93.

Balbinot LF. Diagnóstico de neuropatia no diabetes mellitus tipo 2 e no pré-diabetes [Tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2012.

Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice: Oxford University Press; 2013.

Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes care. 2010;33(7):1549-54.

Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, et al. Scoring systems to screen for diabetic peripheral neuropathy - The Cochrane Collaboration. Cochrane database syst rev. 2014.

Arap A, Siqueira SR, Silva CB, Teixeira MJ, Siqueira JT. Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch oral biol. 2010;55(7):486-93.

Downloads

Published

2016-05-17

Issue

Section

Epidemiology

Most read articles by the same author(s)